Learn More
Selleck Chemical LLC DMXAA (Vadimezan) 25mg 117570-53-3 NSC 640488, ASA-404

Supplier: Selleck Chemical LLC S153725MG

DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 ?M and IC50 of 62.5 ?M in cell-free assays, respectively. DMXAA (Vadimezan) is also a STING agonist with potential antineoplastic activity. DMXAA (Vadimezan) potently induces IFN-? but relatively low TNF-? expression in vitro. DMXAA (Vadimezan) has antiviral activity. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.